CLEVELAND BIOLABS INC (32)

Browse by Contract Category

Contracts

Amended and Restated Registration Rights Agreement, dated as of July 27, 2021, by and among GEM Global Yield LLC SCS, GEM Yield Bahamas Limited and Cytocom Inc (Filed With SEC on August 2, 2021)
Form of 2021 Warrants (Filed With SEC on August 2, 2021)
Executive Employment Agreement, dated as of August 19, 2020, as amended, by and among Cytocom Inc. and Michael K. Handley (Filed With SEC on July 28, 2021)
Form of Voting and Support Agreement (Filed With SEC on October 19, 2020)
Merger Agreement, dated as of October 16, 2020, between Cleveland Biolabs, Inc., High Street Acquisition Corp. and Cytocom, Inc (Filed With SEC on October 19, 2020)
Warrant to Purchase Shares of Cytocom Inc., dated as of July 27, 2021, issued to GEM Yield Bahamas Limited (Filed With SEC on August 2, 2021)
Amended and Restated Share Purchase Agreement, dated as of July 27, 2021, by and among GEM Global Yield LLC SCS, GEM Yield Bahamas Limited and Cytocom Inc (Filed With SEC on August 2, 2021)
Warrant to Purchase Shares of Common Stock of Cytocom Inc., dated as of July 27, 2021, issued to Avenue Venture Opportunities Fund, L.P (Filed With SEC on August 2, 2021)
Supplement to the Loan and Security Agreement dated as of April 26, 2021 between Cytocom, Inc. and Avenue Venture Opportunities Fund, L.P (Filed With SEC on August 2, 2021)
Loan and Security Agreement, dated as of April 26, 2021, by and among Cytocom, Inc. and Avenue Venture Opportunities Fund, L.P (Filed With SEC on August 2, 2021)
Amendment No. 2 to Executive Employment Agreement, dated as of October 31, 2020, by and among Cytocom Inc. and Peter Aronstam (Filed With SEC on July 28, 2021)
Amendment No. 1 to Executive Employment Agreement, dated as of September 6, 2020, by and among Cytocom Inc. and Peter Aronstam (Filed With SEC on July 28, 2021)
Executive Employment Agreement, dated as of August 17, 2020, as amended, by and among Cytocom Inc. and Peter Aronstam (Filed With SEC on July 28, 2021)
Amendment No. 1 to Executive Employment Agreement, dated as of March 8, 2021, by and among Cytocom Inc. and Taunia Markvicka (Filed With SEC on July 28, 2021)
Executive Employment Agreement, dated as of October 30, 2020, as amended, by and among Cytocom Inc. and Taunia Markvicka (Filed With SEC on July 28, 2021)
Amendment No. 2 to Executive Employment Agreement, dated as of October 31, 2020, by and among Cytocom Inc. and Michael K. Handley (Filed With SEC on July 28, 2021)
Amendment No. 1 to Executive Employment Agreement, dated as of September 6, 2020, by and among Cytocom Inc. and Michael K. Handley (Filed With SEC on July 28, 2021)
Form of Securities Purchase Agreement, dated as of February 19, 2021, between Cleveland BioLabs, Inc. and the purchasers named therein (Filed With SEC on February 23, 2021)
Form of Placement Agent Warrant (Filed With SEC on February 23, 2021)
Award/Contract W81XWH-15-0570 modification dated September 29, 2020 issued by USA Med Research ACQ Activity (Filed With SEC on November 16, 2020)
Award/Contract W81XWH-15-0101 modification dated September 29, 2020 issued by USA Med Research ACQ Activity (Filed With SEC on November 16, 2020)
Consulting Agreement, dated as of October 11, 2020, between Cleveland BioLabs, Inc. and Andrei Gudkov, , Ph.D., D. Sci (Filed With SEC on October 13, 2020)
Consulting Agreement, dated as of August 10, 2020, between Cleveland BioLabs, Inc. and Sound Clinical Solutions, SP (Filed With SEC on August 14, 2020)
Award/Contract W81XWH-15-0570 modification dated July 31, 2020 issued by USA Med Research ACQ Activity (Filed With SEC on August 14, 2020)
Settlement and General Release Agreement, dated as of July 15, 2020, between Cleveland BioLabs, Inc. and Alpha Capital Anstalt (Filed With SEC on August 14, 2020)
Award/Contract W81XWH-15-0101 modification dated July 31, 2020 issued by USA Med Research ACQ Activity (Filed With SEC on July 31, 2020)
Form of Securities Purchase Agreement, dated as of June 1, 2020, between Cleveland BioLabs, Inc. and the purchasers named therein (Filed With SEC on June 3, 2020)
Form of Placement Agent Warrant (Filed With SEC on June 3, 2020)
Form of Warrant (Filed With SEC on June 3, 2020)
Award/Contract W81XWH-15-0101 modification dated March 18, 2020 issued by USA Med Research ACQ Activity (Filed With SEC on April 15, 2020)
Description of Registrant's Securities (Filed With SEC on April 15, 2020)
Award/Contract W81XWH-15-C-0101 modification dated February 28, 2019 issued by USA Med Research ACQ Activity (Filed With SEC on May 15, 2019)